Apogee Therapeutics Files 8-K on Financials and Operations
Ticker: APGE · Form: 8-K · Filed: May 12, 2025 · CIK: 1974640
| Field | Detail |
|---|---|
| Company | Apogee Therapeutics, Inc. (APGE) |
| Form Type | 8-K |
| Filed Date | May 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, operations, filing
Related Tickers: APGE
TL;DR
APGE dropped an 8-K detailing financials & operations - check it out.
AI Summary
On May 12, 2025, Apogee Therapeutics, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, along with Regulation FD disclosures and other events. It also includes financial statements and exhibits.
Why It Matters
This 8-K filing provides investors with crucial updates on Apogee Therapeutics' financial health and operational status, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine filing of financial and operational information, not indicating any immediate adverse events.
Key Players & Entities
- Apogee Therapeutics, Inc. (company) — Registrant
- May 12, 2025 (date) — Date of earliest event reported
- Waltham, MA (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Apogee Therapeutics, Inc.?
The primary purpose of this 8-K filing is to report on Apogee Therapeutics, Inc.'s results of operations and financial condition, along with Regulation FD disclosures and other events, and to include financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on May 12, 2025.
Where are Apogee Therapeutics, Inc.'s principal executive offices located?
Apogee Therapeutics, Inc.'s principal executive offices are located at 221 Crescent Street, Building 17, Suite 102b, Waltham, MA, 02453.
What is the Standard Industrial Classification (SIC) code for Apogee Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Apogee Therapeutics, Inc. is 2836, which corresponds to BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
What was Apogee Therapeutics' former company name and when did the name change occur?
Apogee Therapeutics' former company name was Apogee Therapeutics, LLC, and the date of the name change was April 20, 2023.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 12, 2025 regarding Apogee Therapeutics, Inc. (APGE).